Persistent Pyelonephritis and Renal Abscess due to Mycoplasma hominis in an Immunocompromised Patient: A Case Report
Abstract
Background: Mycoplasma hominis is a fastidious, cell wall-deficient bacterium commonly colonising the lower genitourinary tract. While usually commensal, it can cause opportunistic infections in immunocompromised patients. As it can be difficult to culture on standard mediums and is resistant to many first-line antimicrobials, diagnosis and treatment are often delayed.
Case presentation: We report the case of a 31-year-old woman with Stage IVA extranodal marginal zone lymphoma previously treated with bendamustine-rituximab, who presented with fever, suprapubic pain and haematuria in the setting of neutropenia. She developed acute kidney injury and was initially treated for neutropenic sepsis. Computed tomography revealed bilateral hydroureteronephrosis and, subsequently, a right renal lesion concerning for abscess. Despite broad-spectrum empirical therapy, she remained febrile with persistently elevated inflammatory markers. Blood cultures grew Streptococcus mitis in a single bottle, later considered a contaminant. Routine urine cultures were initially negative; M. hominis was identified only after prolonged incubation and directed testing on a urine culture collected on Day 5 of admission. On Day 10 of admission, urine culture identified Mycoplasma hominis. Directed therapy with intravenous clindamycin, doxycycline and levofloxacin led to clinical improvement. She was discharged after 17 days with a combination of oral doxycycline and levofloxacin. She was readmitted…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.